Studying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic Leukemia
|ClinicalTrials.gov Identifier: NCT01626183|
Recruitment Status : Completed
First Posted : June 22, 2012
Last Update Posted : May 17, 2016
RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer
PURPOSE: This laboratory study is looking into RNA in samples from younger patients with T-cell (T) acute lymphoblastic leukemia (ALL).
|Condition or disease||Intervention/treatment|
|Leukemia||Genetic: RNA analysis Genetic: proteomic profiling Other: laboratory biomarker analysis|
- Characterization of the transcriptomic landscape in diagnosis and relapse of T-cell acute lymphoblastic leukemia (ALL) and the direct comparison with corresponding physiological samples (human thymus).
- Perform high-throughput transcriptome ribonucleic acid (RNA) sequencing using matched diagnostic T-precursor pediatric ALL samples (peripheral blood or bone marrow).
OUTLINE: Archived peripheral blood and bone marrow samples are analyzed for long non-coding RNA (IncRNA) expression and sequencing.
|Study Type :||Observational|
|Estimated Enrollment :||20 participants|
|Official Title:||Molecular Taxonomy in Pediatric Cancer- IncRNA Expression in Primary T-ALL|
|Study Start Date :||May 2012|
|Actual Primary Completion Date :||May 2016|
|Actual Study Completion Date :||May 2016|
- Identification and characterization of IncRNA of pediatric T-cell acute lymphoblastic leukemia
Biospecimen Retention: Samples With DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01626183
|Principal Investigator:||Iannis Aifantis, PhD||New York University School of Medicine|